Alignment Healthcare, Inc. (ALHC)
NASDAQ: ALHC · Real-Time Price · USD
19.55
+0.15 (0.77%)
At close: Dec 5, 2025, 4:00 PM EST
19.21
-0.34 (-1.74%)
After-hours: Dec 5, 2025, 5:23 PM EST
Alignment Healthcare Stock Forecast
Stock Price Forecast
The 11 analysts with 12-month price forecasts for Alignment Healthcare stock have an average target of 19.77, with a low estimate of 17 and a high estimate of 23. The average target predicts an increase of 1.13% from the current stock price of 19.55.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Alignment Healthcare stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jul '25 | Aug '25 | Sep '25 | Oct '25 | Nov '25 | Dec '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 4 | 3 | 3 |
| Buy | 4 | 5 | 5 | 4 | 5 | 5 |
| Hold | 4 | 3 | 3 | 3 | 3 | 3 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 11 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Hold → Buy Upgrades $18 → $20 | Hold → Buy | Upgrades | $18 → $20 | +2.30% | Nov 24, 2025 |
| JP Morgan | JP Morgan | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -7.93% | Nov 5, 2025 |
| Barclays | Barclays | Hold Maintains $13 → $18 | Hold | Maintains | $13 → $18 | -7.93% | Nov 3, 2025 |
| UBS | UBS | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | -7.93% | Oct 31, 2025 |
| Goldman Sachs | Goldman Sachs | Strong Buy Initiates $21 | Strong Buy | Initiates | $21 | +7.42% | Oct 14, 2025 |
Financial Forecast
Revenue This Year
4.02B
from 2.70B
Increased by 48.51%
Revenue Next Year
5.20B
from 4.02B
Increased by 29.61%
EPS This Year
-0.11
from -0.67
EPS Next Year
0.10
from -0.11
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.1B | 5.8B | |||
| Avg | 4.0B | 5.2B | |||
| Low | 3.8B | 4.8B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 53.2% | 44.7% | |||
| Avg | 48.5% | 29.6% | |||
| Low | 41.5% | 20.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | -0.09 | 0.20 | ||
| Avg | -0.11 | 0.10 | ||
| Low | -0.13 | - |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | - | ||
| Avg | - | - | ||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.